BD & Opentrons Collaborate, Hoth & NVIDIA Team Up, EY's Big AI Acquisition - Life AI Weekly #38

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we're spotlighting several significant collaborations and innovations. BD and Opentrons have teamed up to enhance AI-driven research, while Hoth Therapeutics is partnering with NVIDIA to integrate AI into drug development processes. Additionally, Cumulus Neuroscience is showcasing its AI innovations at various conferences, and Bioforum has joined forces with PhaseV to revolutionize AI trial design.

In the realm of business and investments, POMDOCTOR LIMITED has announced its IPO pricing, and EY has acquired Aqurance to bolster AI capabilities in life sciences. The Novo Nordisk Foundation is funding an AI platform for pathogen analysis, and Adlib has renewed its SOC 2 and HIPAA compliance. Stay tuned as we explore these developments and more in this edition.

POMDOCTOR LIMITED has announced the pricing of its initial public offering to support the expansion of its AI-driven healthcare services. Meanwhile, the EY organization has acquired Aqurance to enhance its AI-driven solutions in the life sciences sector, focusing on improving efficiency and compliance for global pharma and biotech clients.

BD and Opentrons have announced a multi-year partnership to integrate robotic automation into BD's single-cell multiomics instruments, aiming to enhance disease research and drug development. Meanwhile, Hoth Therapeutics has partnered with NVIDIA to leverage AI technologies for accelerating the discovery and development of new therapeutics.

TransCelerate has introduced the Digital Data Flow Initiative to enhance AI adoption in clinical trials, focusing on streamlining data processes for improved efficiency and accuracy. Meanwhile, Biostate AI has launched K-Dense Beta, an AI system developed with Harvard Medical School to significantly reduce the time required for biological research cycles.

BD and Opentrons collaborate on AI-driven research to enhance drug discovery. Hoth Therapeutics partners with NVIDIA to integrate AI in drug development processes. Cumulus Neuroscience showcases its AI innovations at various conferences. Bioforum partners with PhaseV to design AI-driven clinical trials.

DPR Construction has released a report highlighting AI's impact on healthcare construction, emphasizing efficiency and growth. Meanwhile, Notable launched Flow AI on October 7, 2025, to streamline workflow automation in healthcare settings.